Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment.

Michael Cronquist Christensen,Roger S McIntyre,Ioana Florea,Henrik Loft,Andrea Fagiolini

CNS spectrums（2023）

引用 11|浏览11

暂无评分

摘要

Vortioxetine 20 mg is significantly more effective than vortioxetine 10 mg in patients with MDD, with a similar tolerability profile. In flexible-dose studies, almost half of all patients received 20 mg/day after 1 week and two-thirds received 20 mg/day as their final dosage.

查看译文

关键词

dosage,efficacy,major depressive disorder,tolerability,treatment optimization,vortioxetine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要